Breathe Well Live Well
|
Wake Forest Baptist announces findings of asthma study
Winston-Salem Journal An asthma study led by Wake Forest Baptist Medical Center researchers finds that rare genetic variations may account for severe reaction in some people to several types of asthma-treatment drugs. Long-acting beta agonists, or LABAs, are among the most … |
View full post on asthma – Google News
|
UPDATE Targacept loses big shareholder, finds error in previous study
Winston-Salem Journal (blog) Targacept Inc.'s rollercoaster ride – financially and in research – dropped again today with the news that a recent asthma study did not perform as first stated on March 27. The company, based in Winston-Salem, also learned in a regulatory filing … |
View full post on asthma – Google News
|
Targacept loses big shareholder, finds error in previous study
Winston-Salem Journal Targacept Inc.'s rollercoaster ride – financially and in research – dropped again today with the news that a recent asthma study did not perform as first stated on March 27. The company, based in Winston-Salem, also learned in a regulatory filing … |
View full post on asthma – Google News
|
Targacept to begin Phase 2 trials of drug that could treat asthma, diabetes
Winston-Salem Journal Type 2 diabetes affects 198 million worldwide, and asthma affects about 65 million in just the world's seven major pharmaceutical markets — France, Germany … Targacept starts new trial for diabetes drug TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and … |
View full post on asthma – Google News
|
Targacept to begin phase 2 trials for its anti-inflammatory drug compound
Winston-Salem Journal … said that the studies involve its drug compound TC-6987 for disorders related to inflammation – in this instance asthma and Type 2 diabetes. … Targacept starts new trial for diabetes drug TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and … |
View full post on asthma – Google News